Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOTULINUM TOXIN TYPE A vs BREXPIPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOTULINUM TOXIN TYPE A vs BREXPIPRAZOLE: Safety Overview

Metric BOTULINUM TOXIN TYPE A BREXPIPRAZOLE
Total FAERS Reports 3,742 13,270
Deaths Reported 1,288 673
Death Rate 34.4% 5.1%
Hospitalizations 1,536 1,269
Average Patient Age 44.1 yrs 50.5 yrs
% Female Patients 78.8% 69.0%
FDA Approval Date N/A Aug 11, 2022
Manufacturer Evolus, Inc. Otsuka America Pharmaceutical, Inc.
Route INTRAMUSCULAR ORAL
Marketing Status N/A Prescription